av/aprea-therapeutics--big.svg

NASDAQ:APRE

Aprea Therapeutics, Inc.

  • Stock

USD

Last Close

3.81

26/07 20:00

Market Cap

21.45M

Beta: -

Volume Today

3.70K

Avg: 15.86K

PE Ratio

−0.19

PFCF: −1.88

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
583.23K
-
cost of revenue
170.25K
-
229.61K
34.86%
271.68K
18.32%
186.44K
31.37%
7.05K
96.22%
gross profit
-170.25K
-
-229.61K
34.86%
-271.68K
18.32%
-186.44K
31.37%
576.18K
409.03%
selling and marketing expenses
-7.05K
-
general and administrative expenses
2.46M
-
2.29M
6.71%
8.59M
274.50%
14.93M
73.76%
13.55M
9.25%
20.97M
54.75%
8.43M
59.81%
selling general and administrative expenses
2.46M
-
2.29M
6.71%
8.59M
274.50%
14.93M
73.76%
13.55M
9.25%
20.97M
54.75%
8.42M
59.84%
research and development expenses
13.39M
-
14.19M
5.99%
20.95M
47.59%
37.88M
80.80%
23.90M
36.92%
16.40M
31.36%
7.63M
53.50%
other expenses
76.02M
-
cost and expenses
15.85M
-
16.49M
4.02%
29.54M
79.17%
52.81M
78.75%
37.45M
29.09%
37.37M
0.20%
16.06M
57.04%
operating expenses
15.85M
-
16.49M
4.02%
29.54M
79.17%
52.81M
78.75%
37.45M
29.09%
37.37M
0.20%
16.05M
57.06%
interest expense
15
-
182
1,113.33%
156.35K
85,807.14%
222.65K
42.41%
448.67K
-
ebitda
-16.51M
-
-16.48M
0.15%
-30.87M
87.32%
-51.92M
68.18%
-37.76M
27.27%
38.37M
201.60%
-15.46M
140.31%
operating income
-15.85M
-
-16.49M
4.02%
-31.04M
88.26%
-52.15M
68.00%
-38.04M
27.07%
38.18M
200.38%
-15.47M
140.52%
depreciation and amortization
7.93K
-
8.32K
4.84%
170.25K
1,947.31%
229.61K
34.86%
271.68K
18.32%
186.44K
31.37%
7.05K
96.22%
total other income expenses net
662.14K
-
961.32K
45.18%
2.98M
210.29%
-1.33M
144.53%
908.13K
168.37%
-150.84M
16,710.22%
1.19M
100.79%
income before tax
-15.19M
-
-15.53M
2.23%
-28.06M
80.70%
-53.48M
90.59%
-37.13M
30.58%
-112.66M
203.45%
-14.29M
87.32%
income tax expense
-662.13K
-
961.32K
245.19%
-1.65M
272.13%
437.99K
126.47%
-590.73K
234.87%
112.21M
19,095.81%
-2
100.00%
net income
-15.19M
-
-15.53M
2.23%
-26.41M
70.05%
-53.92M
104.19%
-36.54M
32.24%
-224.88M
515.48%
-14.29M
93.65%
weighted average shs out
703.78K
-
703.78K
0%
300.12K
57.36%
1.06M
252.08%
1.06M
0.72%
82.85K
92.22%
3.62M
4,266.35%
weighted average shs out dil
703.78K
-
703.78K
0%
300.12K
57.36%
1.06M
252.08%
1.06M
0.72%
82.85K
92.22%
3.62M
4,266.35%
eps
-21.58
-
-22.06
2.22%
-87.98
298.82%
-51.02
42.01%
-34.33
32.71%
-2.71K
7,806.15%
-3.95
99.85%
epsdiluted
-21.58
-
-22.06
2.22%
-87.98
298.82%
-51.02
42.01%
-34.33
32.71%
-2.71K
7,806.15%
-3.95
99.85%

All numbers in USD (except ratios and percentages)